Cargando…

Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial

Detalles Bibliográficos
Autores principales:	Bosteels, Cedric, Maes, Bastiaan, Van Damme, Karel, De Leeuw, Elisabeth, Declercq, Jozefien, Delporte, Anja, Demeyere, Bénédicte, Vermeersch, Stéfanie, Vuylsteke, Marnik, Willaert, Joren, Bollé, Laura, Vanbiervliet, Yuri, Decuypere, Jana, Libeer, Frederick, Vandecasteele, Stefaan, Peene, Isabelle, Lambrecht, Bart N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306655/ https://www.ncbi.nlm.nih.gov/pubmed/32571428 http://dx.doi.org/10.1186/s13063-020-04520-x

Ejemplares similares

Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial
por: Bosteels, Cedric, et al.
Publicado: (2020)

Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
por: Maes, Bastiaan, et al.
Publicado: (2020)

Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
por: Maes, Bastiaan, et al.
Publicado: (2020)

Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial
por: Declercq, Jozefien, et al.
Publicado: (2020)

Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent
por: Declercq, Jozefien, et al.
Publicado: (2022)

Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19
por: Van Damme, Karel F. A., et al.
Publicado: (2020)

Safety and efficacy of sargramostim (GM‐CSF) in the treatment of Alzheimer's disease
por: Potter, Huntington, et al.
Publicado: (2021)

Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
por: Abdelmoaty, Mai M., et al.
Publicado: (2022)

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
por: Bosteels, Cedric, et al.
Publicado: (2022)

Potential association between membranous nephropathy and sargramostim therapy for pulmonary alveolar proteinosis
por: Sewaralthahab, Kamal, et al.
Publicado: (2014)

Boosting Abscopal Response to Radiotherapy with Sargramostim: A Review of Data and Ongoing Studies
por: Leary, Robyn, et al.
Publicado: (2019)

Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease
por: Olson, Katherine E., et al.
Publicado: (2021)

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
por: De Leeuw, Elisabeth, et al.
Publicado: (2022)

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
por: Declercq, Jozefien, et al.
Publicado: (2021)

Association of Cell Death Markers With Tumor Immune Cell Infiltrates After Chemo-Radiation in Cervical Cancer
por: Oltean, Teodora, et al.
Publicado: (2022)

Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?
por: Lazarus, Hillard M., et al.
Publicado: (2021)

Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors
por: Schuelke, Matthew R, et al.
Publicado: (2022)

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial
por: Gendelman, Howard E., et al.
Publicado: (2017)

Comparison of the effects of tranexamic acid, aprotinin and placebo on blood conservation, fibrinolysis and platelet function with extensive heart surgery
por: Demeyere, R, et al.
Publicado: (2006)

TIM3(+) TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16(+) NK cells delineate MIS-C
por: Hoste, Levi, et al.
Publicado: (2021)

Linkage Mapping Identifies the Sex Determining Region as a Single Locus in the Pennate Diatom Seminavis robusta
por: Vanstechelman, Ives, et al.
Publicado: (2013)

Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing
por: Van den Hoecke, Silvie, et al.
Publicado: (2015)

An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers
por: Olson, Katherine E., et al.
Publicado: (2023)

Ionizing radiation results in a mixture of cellular outcomes including mitotic catastrophe, senescence, methuosis, and iron-dependent cell death
por: Adjemian, Sandy, et al.
Publicado: (2020)

Characterization of genome-wide ordered sequence-tagged Mycobacterium mutant libraries by Cartesian Pooling-Coordinate Sequencing
por: Vandewalle, Kristof, et al.
Publicado: (2015)

Protein interactors of 3-O sulfated heparan sulfates in human MCI and age-matched control cerebrospinal fluid
por: Ferreira, Andreia, et al.
Publicado: (2023)

A first AFLP-Based Genetic Linkage Map for Brine Shrimp Artemia franciscana and Its Application in Mapping the Sex Locus
por: De Vos, Stephanie, et al.
Publicado: (2013)

Continuous Mapping Identifies Loci Associated With Weevil Resistance [Cosmopolites sordidus (Germar)] in a Triploid Banana Population
por: Uwimana, Brigitte, et al.
Publicado: (2021)

New Technologies in Rhinoplasty: A Comprehensive Workflow for Computer-assisted Planning and Execution
por: Willaert, Robin V., et al.
Publicado: (2019)

Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza B
por: Portela Catani, João Paulo, et al.
Publicado: (2023)

Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm)
por: Paine, Robert, et al.
Publicado: (2022)

Encephalopathy associated with autoimmune thyroid disease: a rare but frequently missed neuropsychiatric syndrome
por: Vermeersch, Gaël, et al.
Publicado: (2021)

From prediction to function: Current practices and challenges towards the functional characterization of type III effectors
por: De Ryck, Joren, et al.
Publicado: (2023)

Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice
por: Van Damme, Karel F. A., et al.
Publicado: (2023)

RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)
por: Martens, Sofie, et al.
Publicado: (2018)

MLKL deficiency in Braf(V600E)Pten(−/−) melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice
por: Martens, Sofie, et al.
Publicado: (2022)

Keeping in Touch with Type-III Secretion System Effectors: Mass Spectrometry-Based Proteomics to Study Effector–Host Protein–Protein Interactions
por: Meyer, Margaux De, et al.
Publicado: (2020)

Genome-wide screening for cis-regulatory variation using a classical diallel crossing scheme
por: Kiekens, Raphaël, et al.
Publicado: (2007)

Genome-wide screening for cis-regulatory variation using a classical diallel crossing scheme
por: Kiekens, Raphaël, et al.
Publicado: (2006)

Ejection fraction (EF) corrected volumetric parameters better reflect preload and fluid responsiveness
por: Malbrain, M, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_dju02dev17dgjk5o6f4kt3ileq